Filana Therapeutics, Inc.
FLNA· Nasdaq
FLNAFilana Therapeutics, Inc.
Filed Nov 7, 2024 · 10-Q · 38 days after period end · 0001437749-24-033944
| Metric | Q3 2024 | Q3 2023 | Q3 2022 | Q3 2021 |
|---|---|---|---|---|
| Net Income | -$27.94M | -$25.65M | -$20.26M | -$9.56M |
| EPS Diluted | -$0.58 | -$0.61 | — | -$0.24 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Filana Therapeutics, Inc. · CIK 1069530 · Engraved from SEC EDGAR
ended Sep 30, 2024 · filed Nov 7, 2024 · 38 d after period end
